The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Diseases Diagnostic Testing Market Research Report 2025
Synopsis
Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases
The global Respiratory Diseases Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Diseases Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Diseases Diagnostic Testing.
Report Scope
The Respiratory Diseases Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Diseases Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Diseases Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips Healthcare
BD
Abbott
Thermo Fisher Scientific
Roche
ResMed
Fischer & Paykel
Medtronic
MGC Diagnostics
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Diseases Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases
The global Respiratory Diseases Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Diseases Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Diseases Diagnostic Testing.
Report Scope
The Respiratory Diseases Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Diseases Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Diseases Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips Healthcare
BD
Abbott
Thermo Fisher Scientific
Roche
ResMed
Fischer & Paykel
Medtronic
MGC Diagnostics
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Diseases Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Respiratory Diseases Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Diseases Diagnostic Testing Market Perspective (2019-2030)
2.2 Respiratory Diseases Diagnostic Testing Growth Trends by Region
2.2.1 Global Respiratory Diseases Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Diseases Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Diseases Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Diseases Diagnostic Testing Market Dynamics
2.3.1 Respiratory Diseases Diagnostic Testing Industry Trends
2.3.2 Respiratory Diseases Diagnostic Testing Market Drivers
2.3.3 Respiratory Diseases Diagnostic Testing Market Challenges
2.3.4 Respiratory Diseases Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Diseases Diagnostic Testing Players by Revenue
3.1.1 Global Top Respiratory Diseases Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Diseases Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Diseases Diagnostic Testing Revenue
3.4 Global Respiratory Diseases Diagnostic Testing Market Concentration Ratio
3.4.1 Global Respiratory Diseases Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Diseases Diagnostic Testing Revenue in 2023
3.5 Respiratory Diseases Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Respiratory Diseases Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Respiratory Diseases Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Diseases Diagnostic Testing Breakdown Data by Type
4.1 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Respiratory Diseases Diagnostic Testing Breakdown Data by Application
5.1 Global Respiratory Diseases Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Diseases Diagnostic Testing Market Size (2019-2030)
6.2 North America Respiratory Diseases Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Diseases Diagnostic Testing Market Size (2019-2030)
7.2 Europe Respiratory Diseases Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Diseases Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Respiratory Diseases Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips Healthcare
11.1.1 Philips Healthcare Company Detail
11.1.2 Philips Healthcare Business Overview
11.1.3 Philips Healthcare Respiratory Diseases Diagnostic Testing Introduction
11.1.4 Philips Healthcare Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.1.5 Philips Healthcare Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Respiratory Diseases Diagnostic Testing Introduction
11.2.4 BD Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.2.5 BD Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Diseases Diagnostic Testing Introduction
11.3.4 Abbott Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Respiratory Diseases Diagnostic Testing Introduction
11.5.4 Roche Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.5.5 Roche Recent Development
11.6 ResMed
11.6.1 ResMed Company Detail
11.6.2 ResMed Business Overview
11.6.3 ResMed Respiratory Diseases Diagnostic Testing Introduction
11.6.4 ResMed Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.6.5 ResMed Recent Development
11.7 Fischer & Paykel
11.7.1 Fischer & Paykel Company Detail
11.7.2 Fischer & Paykel Business Overview
11.7.3 Fischer & Paykel Respiratory Diseases Diagnostic Testing Introduction
11.7.4 Fischer & Paykel Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.7.5 Fischer & Paykel Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Detail
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Respiratory Diseases Diagnostic Testing Introduction
11.8.4 Medtronic Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.8.5 Medtronic Recent Development
11.9 MGC Diagnostics
11.9.1 MGC Diagnostics Company Detail
11.9.2 MGC Diagnostics Business Overview
11.9.3 MGC Diagnostics Respiratory Diseases Diagnostic Testing Introduction
11.9.4 MGC Diagnostics Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024)
11.9.5 MGC Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imaging Test
Table 3. Key Players of Respiratory Measurement
Table 4. Key Players of Blood Gas Test
Table 5. Key Players of Other
Table 6. Global Respiratory Diseases Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Respiratory Diseases Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Respiratory Diseases Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Respiratory Diseases Diagnostic Testing Market Share by Region (2019-2024)
Table 10. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Respiratory Diseases Diagnostic Testing Market Share by Region (2025-2030)
Table 12. Respiratory Diseases Diagnostic Testing Market Trends
Table 13. Respiratory Diseases Diagnostic Testing Market Drivers
Table 14. Respiratory Diseases Diagnostic Testing Market Challenges
Table 15. Respiratory Diseases Diagnostic Testing Market Restraints
Table 16. Global Respiratory Diseases Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Respiratory Diseases Diagnostic Testing Market Share by Players (2019-2024)
Table 18. Global Top Respiratory Diseases Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2023)
Table 19. Ranking of Global Top Respiratory Diseases Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Respiratory Diseases Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Respiratory Diseases Diagnostic Testing Product Solution and Service
Table 23. Date of Enter into Respiratory Diseases Diagnostic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Diseases Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 27. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 29. Global Respiratory Diseases Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 31. Global Respiratory Diseases Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Respiratory Diseases Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 33. North America Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Philips Healthcare Company Detail
Table 49. Philips Healthcare Business Overview
Table 50. Philips Healthcare Respiratory Diseases Diagnostic Testing Product
Table 51. Philips Healthcare Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 52. Philips Healthcare Recent Development
Table 53. BD Company Detail
Table 54. BD Business Overview
Table 55. BD Respiratory Diseases Diagnostic Testing Product
Table 56. BD Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 57. BD Recent Development
Table 58. Abbott Company Detail
Table 59. Abbott Business Overview
Table 60. Abbott Respiratory Diseases Diagnostic Testing Product
Table 61. Abbott Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. Thermo Fisher Scientific Company Detail
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Respiratory Diseases Diagnostic Testing Product
Table 66. Thermo Fisher Scientific Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Roche Company Detail
Table 69. Roche Business Overview
Table 70. Roche Respiratory Diseases Diagnostic Testing Product
Table 71. Roche Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 72. Roche Recent Development
Table 73. ResMed Company Detail
Table 74. ResMed Business Overview
Table 75. ResMed Respiratory Diseases Diagnostic Testing Product
Table 76. ResMed Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 77. ResMed Recent Development
Table 78. Fischer & Paykel Company Detail
Table 79. Fischer & Paykel Business Overview
Table 80. Fischer & Paykel Respiratory Diseases Diagnostic Testing Product
Table 81. Fischer & Paykel Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 82. Fischer & Paykel Recent Development
Table 83. Medtronic Company Detail
Table 84. Medtronic Business Overview
Table 85. Medtronic Respiratory Diseases Diagnostic Testing Product
Table 86. Medtronic Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 87. Medtronic Recent Development
Table 88. MGC Diagnostics Company Detail
Table 89. MGC Diagnostics Business Overview
Table 90. MGC Diagnostics Respiratory Diseases Diagnostic Testing Product
Table 91. MGC Diagnostics Revenue in Respiratory Diseases Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 92. MGC Diagnostics Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Diseases Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Respiratory Diseases Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Imaging Test Features
Figure 4. Respiratory Measurement Features
Figure 5. Blood Gas Test Features
Figure 6. Other Features
Figure 7. Global Respiratory Diseases Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Respiratory Diseases Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Physician Clinics Case Studies
Figure 11. Clinical Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Respiratory Diseases Diagnostic Testing Report Years Considered
Figure 14. Global Respiratory Diseases Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Respiratory Diseases Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Respiratory Diseases Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 17. Global Respiratory Diseases Diagnostic Testing Market Share by Players in 2023
Figure 18. Global Top Respiratory Diseases Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Diseases Diagnostic Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Respiratory Diseases Diagnostic Testing Revenue in 2023
Figure 20. North America Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Respiratory Diseases Diagnostic Testing Market Share by Country (2019-2030)
Figure 22. United States Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Respiratory Diseases Diagnostic Testing Market Share by Country (2019-2030)
Figure 26. Germany Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Respiratory Diseases Diagnostic Testing Market Share by Region (2019-2030)
Figure 34. China Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Respiratory Diseases Diagnostic Testing Market Share by Country (2019-2030)
Figure 42. Mexico Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Respiratory Diseases Diagnostic Testing Market Share by Country (2019-2030)
Figure 46. Turkey Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Respiratory Diseases Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Philips Healthcare Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 49. BD Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 52. Roche Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 53. ResMed Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 54. Fischer & Paykel Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 55. Medtronic Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 56. MGC Diagnostics Revenue Growth Rate in Respiratory Diseases Diagnostic Testing Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
